Valted Seq is a discovery stage biopharmaceutical company spearheaded by world-renowned scientists Dr. Ted Dawson and Dr. Valina Dawson of Johns Hopkins University. The company was founded on the belief that a deeper understanding of neurodegenerative pathways is essential to develop precision therapeutics and identify novel biomarkers for some of the most challenging neurodegenerative diseases, including Alzheimer’s and Parkinson’s. Valted Seq is part of the D&D Pharmatech/Neuraly family of companies, which works hand in hand with leading medical research institutions to advance groundbreaking healthcare innovations.
ValtedSeq is focused on the advancement of NextGen sequencing at the single cell level, as well as developing assays for diagnostic biomarkers,
Company Details
- Employees
- 5
- Address
- 704 Quince Orchard Rd,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.valtedseq.com/
- HQ
- Gaithersburg, Maryland
Valtedseq Questions
Valtedseq's website is https://www.valtedseq.com/
Valtedseq's LinkedIn profile is https://www.linkedin.com/company/valtedseq
Valtedseq has
5 employees.
View email and phone details for 5
employees at Valtedseq.
Valtedseq's industry is
Biotechnology Research
Valtedseq's top competitors are
Johnson & Johnson,
Intersect Diagnostics,
Rubin Insurance Agency, Llc,
D&d Pharmatech,
Maidstone Life Sciences,
Novavax,
Omapix,
Neuraly Inc.,
Aevisbio, Inc,
Industrial Light & Magic.
Valtedseq's categories are Biotechnology Research
